Knoll AG
Developed a chemical process to convert morphine into codeine and manufactured codeine as a pharmaceutical active ingredient for treating cough and pain, offering morphine-like effects with reduced side effects—particularly lower addiction risk.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A